11. SAT0430 Assessment of acr and slicc classification criteria in the asia pacific lupus collaboration cohort. (12th June 2018) Authors: Kandane-Rathnayake, R.; Golder, V.; Louthrenoo, W.; Luo, S.-F.; Wu, Y.-J.; Lateef, A.; Sockalingam, S.; Navarra, S.; Zamora, L.; Hamijoyo, L.; Katsumata, Y.; Harigai, M.; Chan, M.; O'Neill, S.; Goldblatt, F.; Lau, C.S.; Hoi, A.; Nikpour, M.; Morand, E. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 1074 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
12. Spanish Guidelines for the use of Targeted Deep Sequencing in MDS and CMML. (April 2017) Authors: Palomo, L.; Ibáñez, M.; Abáigar, M.; Vázquez, I.; Álvarez, S.; Cabezón, M.; Tazón-Vega, B.; Acha, P.; Benito, R.; Cervera, J.; Cigudosa, J.C.; Fuster-Tormo, F.; Hernández Sánchez, J.M.; Larrayoz, M.J.; Valcárcel, D.; Zamora, L.; Sanz, G.; Calasanz, M.J.; Solé, F.; Such, E. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S16 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
13. Targeted Deep Sequencing of Peripheral CD34+ Cells can Reproduce Bone Marrow Molecular Profile in MDS Patients. (April 2017) Authors: Acha, P.; Martin, R.; Palomo, L.; Ganster, C.; Dierks, S.; Mallo, M.; Ademà, V.; Fuster-Tormo, F.; Gómez-Marzo, P.; De Haro, N.; Jiménez-García, F.; Solanes, N.; Zamora, L.; Xicoy, B.; Kominowski, A.; Stromburg, M.; Brockmann, A.; Truemper, L.; Sole, F.; Haase, D. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S154 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
14. THU0350 Time dependent association of active renal disease with irreversible organ damage accrual in systemic lupus erythematosus. (12th June 2018) Authors: Morand, E.; Kandane-Rathnayake, R.; Louthrenoo, W.; Luo, S.-F.; Wu, Y.-J.; Lateef, A.; Golder, V.; Sockalingam, S.; Navarra, S.; Zamora, L.; Hamijoyo, L.; Katsumata, Y.; Harigai, M.; Chan, M.; O'Neill, S.; Goldblatt, F.; Lau, C.S.; Hoi, A.; Nikpour, M. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 392 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
15. Topic: AS01-Diagnosis/AS01c-Molecular aberrations (cytogenetic, genetic, gene expression): GENOMIC CLASSIFICATION OF MYELODYSPLASTIC SYNDROMES. (May 2023) Authors: Bernard, E.; Hasserjian, R.; Greenberg, P.; Ossa, J. Arango; Creignou, M.; Nannya, Y.; Tuechler, H.; Medina-Martinez, J.; Levine, M.; Jädersten, M.; Germing, U.; Sanz, G.; Van De Loosdrecht, A.; Kosmider, O.; Follo, M.; Thol, F.; Zamora, L.; Pinheiro, R.; Pellagatti, A.; Elias, H. Journal: Leukemia research Issue: Volume 128(2023)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
16. Topic: AS04-MDS Biology and Pathogenesis/AS04b-Clonal diversity & evolution: CLINICAL AND MOLECULAR CHARACTERIZATION OF PATIENTS WITH THERAPY RELATED MYELOID NEOPLASMS. (May 2023) Authors: Calvete, O.; Mestre, J.; Manzanares, A.; Acha, P.; Xicoy, B.; Zamora, L.; Grau, J.; Granada, I.; Diaz, A.; Mora, E.; Such, E.; Montoro, M.J.; Valcárcel, D.; Vahí, M.; Arenillas, L.; Diez-Campelo, M.; Prosper, F.; Solé, F. Journal: Leukemia research Issue: Volume 128(2023)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
17. Topic: AS04-MDS Biology and Pathogenesis/AS04b-Clonal diversity & evolution: SINGLE-CELL MULTIOMICS ANALYSIS OF MYELODYSPLASTIC SYNDROME PREDICTS CLINICAL RESPONSE TO DNA METHYLATION INHIBITOR THERAPY. (May 2023) Authors: Campillo-Marcos, I.; Casado-Pelaez, M.; Davalos, V.; Ferrer, G.; Mata, C.; Mereu, E.; Valcárcel, D.; Molero, A.; Zamora, L.; Palomo, L.; Acha, P.; Manzanares, A.; Solé, F.; Esteller, M. Journal: Leukemia research Issue: Volume 128(2023)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
18. Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment: IMPACT OF GERIATRIC ASSESSMENT AND SOMATIC MUTATIONS IN HIGH-RISK MYELODYSPLASTIC SYNDROMES NOT ELIGIBLE FOR ALO-HCST. CET-AZA-2016–1 2022 UPDATE. ON BEHALF OF THE CETLAM GROUP. (May 2023) Authors: Amer, N.; Cabezón, M.; Xicoy, B.; Garrido, A.; Baena, N.; Canet, M.; Arnan, M.; Arenillas, L.; Coll, R.; Ortin, X.; Diaz, M.; Talarn, C.; García-Caro, M.; Zamora, L.; Bargay, J. Journal: Leukemia research Issue: Volume 128(2023)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
19. Topic: AS07-Singular Entities/Subtypes/AS07e-Chronic myelomonocytic leukemia and overlap syndromes (MDS/MPN): GENOMIC AND TRANSCRIPTOMIC CHARACTERIZATION OF MYELODYSPLASTIC SYNDROMES/MYELOPROLIFERATIVE NEOPLASMS. (May 2023) Authors: Acha, P.; Ezponda, T.; Vilas-Zornoza, A.; Xicoy, B.; Palomo, L.; Fuster-Tormo, F.; Manzanares, A.; Zufiaurre, N. Berastegui; Zamora, L.; Jerez, A.; López-Cadenas, F.; Diez-Campelo, M.; Bonadies, N.; Cervera-Zamora, J.; Mascaró, M.; Montoro, M.J.; Hernández, F.; Raya, J.M.; Ancín, I.; Vahí, M. Journal: Leukemia research Issue: Volume 128(2023)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
20. TP53 Mutations in High Risk Myelodysplastic Syndromes Patients Treated with Azacitidine According to Cetlam Group Protocol. (April 2017) Authors: Cabezón, M.; Bargay, J.; Xicoy, B.; García, O.; Tormo, M.; Palomo, L.; Marcé, S.; Valcárcel, D.; Pedro, C.; Jiménez, M.J.; Borràs, J.; Guàrdia, R.; Brunet, S.; Martí, J.M.; Garcia, A.; Zamora, L. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S155 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗